Antibody Engineering with Novel Technologies Online Symposium on November 20, 2024 in Oxford, United Kingdom

Join global innovators at our symposium on antibody engineering to explore cutting-edge topics such as best practice approaches, advanced therapeutics, and stability strategies. Engage with experts on AI applications and computational tools in antibody engineering. Discuss case studies on achieving stability through advanced methods. The event concludes with the ‘Harnessing Antibody Engineering with Best Practice Approaches’ report summarising key insights and trends for effective utilisation.

This event brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data, and industry outlooks. 

Confirmed speakers include: Kelly Loyet, Distinguished Scientist at Genentech, Norbert Furtmann, Head of AI Innovation - NANOBODY Platform at Sanofi, Philip Kim, Professor at University of Toronto, and Tudor Arvinte, Professor of Biopharmaceuticas at University of Geneva.